Publication date: Jan 12, 2021
GERMAN pharmacist BioNTech, which developed one of the approved covid-19 vaccines together with US-based Pfizer, announces successful trials of mRNA vaccine against multiple sclerosis.
The company has published the first data on the preclinical application of the principle behind its covid-19 vaccine to treat autoimmune diseases such as multiple sclerosis.
In a study published on Friday (January 8) in the journal Science, the company indicates that it has succeeded in developing an mRNA vaccine tested in -complex models of multiple sclerosis in mice” in which suppression of the disease has been detected.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Multiple Sclerosis |
| disease | MESH | autoimmune diseases |
| disease | MESH | development |